Sign In to View Organizational & Contract Pricing.
Select a Size
Change View
About This Item
UNSPSC Code:
41115700
eCl@ss:
32110501
NACRES:
SB.52
L × i.d.:
1 cm × 21.2 mm
Particle size:
10 μm
Matrix active group:
C18 (octadecyl) phase
Pore size:
120 Å
Matrix:
fully porous particle
Product Name
Discovery® HS C18 Prep Guard Cartridge, 10 μm particle size, L × I.D. 1 cm × 21.2 mm
material
stainless steel column
Quality Level
agency
suitable for USP L1
description
Prep Cartridge
product line
Discovery®
feature
endcapped
packaging
pkg of 1 ea
technique(s)
HPLC: suitable, LC/MS: suitable
L × I.D.
1 cm × 21.2 mm
surface area
300 m2/g
matrix
fully porous particle
matrix active group
C18 (octadecyl) phase
particle size
10 μm
pore size
120 Å
operating pH
2-8
application(s)
food and beverages
compatibility
use to protect Discovery HS C18 Prep
separation technique
reversed phase
Still not finding the right product?
Explore all of our products under Discovery® HS C18 Prep Guard Cartridge
Regulatory Information
新产品
This item has
Choose from one of the most recent versions:
Already Own This Product?
Find documentation for the products that you have recently purchased in the Document Library.
Awantika Singh et al.
Rapid communications in mass spectrometry : RCM, 29(6), 485-496 (2015-07-15)
Adhatoda beddomei and Adhatoda vasica are popular Ayurvedic medicinal plants in India, belonging to the family Acanthaceae. Tricyclic quinazoline alkaloids are found to be the most abundant in these plants which are responsible for broad-spectrum medicinal properties. This study aims
Abad Khan et al.
Talanta, 84(3), 789-801 (2011-04-13)
A new, simple, economical and validated high-performance liquid chromatography linked with electrochemical detector (HPLC-ECD) method has been developed and optimized for different experimental parameters to analyze the most common monothiols and disulfide (cystine, cysteine, homocysteine, methionine, reduced (GSH) and oxidized
Swati Jaiswal et al.
Journal of chromatographic science, 55(6), 617-624 (2017-03-24)
Tuberculosis (TB) with human immunodeficiency virus (HIV)/acquired immunodeficiency syndrome represents the most common infectious diseases worldwide. Anti-TB drugs are used concurrently with antiretroviral drug for treatment of TB-HIV co-morbidities. Due to lower risk of interaction with protease inhibitors, rifabutin is
Global Trade Item Number
| SKU | GTIN |
|---|---|
| 581394-U | 04061833518700 |